Oxytocin 30 units added to 0 — Class III drug recall D-0555-2023
Terminated recall by SCA Pharmaceuticals, reported 2023-05-03, distributed nationwide. Subpotent Drug: Out of specification results for low potency was obtained.
| Recall number | D-0555-2023 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SCA Pharmaceuticals, Windsor, CT, United States |
| Recall initiated | 2023-04-10 |
| Classified | 2023-04-27 |
| Reported by FDA | 2023-05-03 |
| Terminated | 2023-09-20 |
| Distributed | Nationwide (US) |
| Quantity | 73,312 containers |
| Reason classes | potency, specification failure |
| NDC | 70004-0085-44 |
| Lot numbers | 1222043028, 1222043029, 1222043031, 1222043032, 1222043033, 1222043034, 1222043035, 1222043036, 1222043037, 1222043038, 1222043039, 1222043040, 1222043041, 1222043042, 1222043043, 1222043044, 1223041990, 1223041991, 1223041992, 1223041993, 1223041996, 1223041997, 1223041998, 1223041999, 1223042000, 1223042001, 1223042002, 1223042003, 1223042004, 1223042006, 1223042007, 1223042008, 1223042009, 1223042010, 1223042766, 1223042767, 1223042769, 1223042770, 1223042771, 1223042772 and 43 more |
Product
Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44
Reason for recall
Subpotent Drug: Out of specification results for low potency was obtained.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0555-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.